Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 527

1.

Preoperative incremental maximum squeeze pressure as a predictor of fecal incontinence after very low anterior resection for low rectal cancer.

Kochi M, Egi H, Adachi T, Takakura Y, Mukai S, Taguchi K, Nakashima I, Sumi Y, Akabane S, Sato K, Yoshinaka H, Hattori M, Ohdan H.

Surg Today. 2019 Dec 3. doi: 10.1007/s00595-019-01926-2. [Epub ahead of print]

PMID:
31797125
2.

Neuromyelitis optica spectrum disorders with unevenly clustered attack occurrence.

Akaishi T, Nakashima I, Takahashi T, Abe M, Ishii T, Aoki M.

Neurol Neuroimmunol Neuroinflamm. 2019 Nov 22;7(1). pii: e640. doi: 10.1212/NXI.0000000000000640. Print 2020 Jan.

3.

Osmotic pressure of serum and cerebrospinal fluid in patients with suspected neurological conditions.

Akaishi T, Takahashi T, Nakashima I, Abe M, Aoki M, Ishii T.

Neural Regen Res. 2020 May;15(5):944-947. doi: 10.4103/1673-5374.268906.

4.

Patterns of regional brain volume loss in multiple sclerosis: a cluster analysis.

Fujimori J, Fujihara K, Ogawa R, Baba T, Wattjes M, Nakashima I.

J Neurol. 2019 Oct 25. doi: 10.1007/s00415-019-09595-4. [Epub ahead of print]

PMID:
31654116
5.

Sensitivity and specificity of meningeal signs in patients with meningitis.

Akaishi T, Kobayashi J, Abe M, Ishizawa K, Nakashima I, Aoki M, Ishii T.

J Gen Fam Med. 2019 Jul 15;20(5):193-198. doi: 10.1002/jgf2.268. eCollection 2019 Sep.

6.

Long-term outcome of a group of Japanese children with myelin-oligodendrocyte glycoprotein encephalomyelitis without preventive immunosuppressive therapy.

Hino-Fukuyo N, Haginoya K, Takahashi T, Nakashima I, Fujihara K, Takai Y, Akasaka M, Kure S.

Brain Dev. 2019 Oct;41(9):790-795. doi: 10.1016/j.braindev.2019.06.004. Epub 2019 Jul 4.

PMID:
31281008
7.

Two Japanese cases of anti-MOG antibody-associated encephalitis that mimicked neuro-Behçet's disease.

Fujimori J, Takahashi T, Matsumoto Y, Fujihara K, Takai Y, Misu T, Nakashima I.

J Neuroimmunol. 2019 Sep 15;334:577002. doi: 10.1016/j.jneuroim.2019.577002. Epub 2019 Jun 29.

PMID:
31279093
8.

Is laparoscopic colorectal surgery with continuation of antiplatelet therapy safe without increasing bleeding complications?

Taguchi K, Shimomura M, Egi H, Hattori M, Mukai S, Kochi M, Sada H, Sumi Y, Nakashima I, Akabane S, Sato K, Ohdan H.

Surg Today. 2019 Nov;49(11):948-957. doi: 10.1007/s00595-019-01839-0. Epub 2019 Jun 22.

9.

Successful treatment of intractable menstrual migraine with the traditional herbal medicine tokishakuyakusan.

Akaishi T, Takayama S, Ohsawa M, Kikuchi A, Arita R, Nakashima I, Aoki M, Ishii T.

J Gen Fam Med. 2019 Apr 3;20(3):118-121. doi: 10.1002/jgf2.242. eCollection 2019 May.

10.

Eculizumab in Aquaporin-4-Positive Neuromyelitis Optica Spectrum Disorder.

Pittock SJ, Berthele A, Fujihara K, Kim HJ, Levy M, Palace J, Nakashima I, Terzi M, Totolyan N, Viswanathan S, Wang KC, Pace A, Fujita KP, Armstrong R, Wingerchuk DM.

N Engl J Med. 2019 Aug 15;381(7):614-625. doi: 10.1056/NEJMoa1900866. Epub 2019 May 3.

PMID:
31050279
11.

Longitudinal changes in 18 F-THK5351 positron emission tomography in corticobasal syndrome.

Ezura M, Kikuchi A, Ishiki A, Okamura N, Hasegawa T, Harada R, Watanuki S, Funaki Y, Hiraoka K, Baba T, Sugeno N, Oshima R, Yoshida S, Kobayashi J, Kobayashi M, Tano O, Nakashima I, Mugikura S, Iwata R, Taki Y, Furukawa K, Arai H, Furumoto S, Tashiro M, Yanai K, Kudo Y, Takeda A, Aoki M.

Eur J Neurol. 2019 Sep;26(9):1205-1211. doi: 10.1111/ene.13966. Epub 2019 May 11.

PMID:
30980575
12.

Outcome prediction models in AQP4-IgG positive neuromyelitis optica spectrum disorders.

Palace J, Lin DY, Zeng D, Majed M, Elsone L, Hamid S, Messina S, Misu T, Sagen J, Whittam D, Takai Y, Leite MI, Weinshenker B, Cabre P, Jacob A, Nakashima I, Fujihara K, Pittock SJ.

Brain. 2019 May 1;142(5):1310-1323. doi: 10.1093/brain/awz054.

13.

The human central nervous system discharges carbon dioxide and lactic acid into the cerebrospinal fluid.

Akaishi T, Onishi E, Abe M, Toyama H, Ishizawa K, Kumagai M, Kubo R, Nakashima I, Aoki M, Yamauchi M, Ishii T.

Fluids Barriers CNS. 2019 Mar 29;16(1):8. doi: 10.1186/s12987-019-0128-7.

14.

Clinical time course of pediatric acute disseminated encephalomyelitis.

Nishiyama M, Nagase H, Tomioka K, Tanaka T, Yamaguchi H, Ishida Y, Toyoshima D, Fujita K, Maruyama A, Sasaki K, Oyazato Y, Nakagawa T, Takami Y, Nozu K, Nishimura N, Nakashima I, Iijima K.

Brain Dev. 2019 Jun;41(6):531-537. doi: 10.1016/j.braindev.2019.02.011. Epub 2019 Mar 2.

PMID:
30833092
15.

Live-cell based assays are the gold standard for anti-MOG-Ab testing.

Yeh EA, Nakashima I.

Neurology. 2019 Mar 12;92(11):501-502. doi: 10.1212/WNL.0000000000007077. Epub 2019 Feb 6. No abstract available.

PMID:
30728306
16.

Clinical significance of assaying anti-MOG antibody in cerebrospinal fluid in MOG-antibody-associated diseases: A case report.

Aoe S, Kume K, Takata T, Touge T, Kaneko K, Nakashima I, Deguchi K, Masaki T.

Mult Scler Relat Disord. 2019 Feb;28:165-166. doi: 10.1016/j.msard.2018.12.035. Epub 2018 Dec 29.

PMID:
30605793
17.

Circulating AQP4-specific auto-antibodies alone can induce neuromyelitis optica spectrum disorder in the rat.

Hillebrand S, Schanda K, Nigritinou M, Tsymala I, Böhm D, Peschl P, Takai Y, Fujihara K, Nakashima I, Misu T, Reindl M, Lassmann H, Bradl M.

Acta Neuropathol. 2019 Mar;137(3):467-485. doi: 10.1007/s00401-018-1950-8. Epub 2018 Dec 18.

18.

Influence of Nutritional Management and Rehabilitation on Physical Outcome in Japanese Intensive Care Unit Patients: A Multicenter Observational Study.

Yatabe T, Egi M, Sakaguchi M, Ito T, Inagaki N, Kato H, Kaminohara J, Konishi A, Takahashi M, Tatsumi H, Tobe M, Nakashima I, Nakamoto N, Nishimura T, Nitta M, Nishimura M.

Ann Nutr Metab. 2019;74(1):35-43. doi: 10.1159/000495213. Epub 2018 Dec 12.

PMID:
30541003
19.

Clinical spectrum of inflammatory central nervous system demyelinating disorders associated with antibodies against myelin oligodendrocyte glycoprotein.

Akaishi T, Sato DK, Takahashi T, Nakashima I.

Neurochem Int. 2019 Nov;130:104319. doi: 10.1016/j.neuint.2018.10.016. Epub 2018 Oct 23. Review.

PMID:
30365980
20.

Surgical techniques for advanced transverse colon cancer using the pincer approach of the transverse mesocolon.

Egi H, Nakashima I, Hattori M, Mukai S, Kochi M, Taguchi K, Sada H, Sumi Y, Ohdan H.

Surg Endosc. 2019 Feb;33(2):639-643. doi: 10.1007/s00464-018-6491-7. Epub 2018 Oct 23.

PMID:
30353241
21.

Abnormal Osmolality Gap Exists in Distal Symmetric Polyneuropathy.

Akaishi T, Takahashi T, Nakashima I, Aoki M.

Tohoku J Exp Med. 2018 Sep;246(1):59-64. doi: 10.1620/tjem.246.59.

22.

A case of ascending colon cancer accompanied with tumor thrombosis in the superior mesenteric vein treated with right hemicolectomy and greater saphenous vein grafting.

Akabane S, Mukai S, Egi H, Adachi T, Kochi M, Sato K, Sumi Y, Nakashima I, Taguchi K, Sada H, Ishikawa A, Yasui W, Ohdan H.

Int J Surg Case Rep. 2018;51:358-363. doi: 10.1016/j.ijscr.2018.09.007. Epub 2018 Sep 9.

23.

Area postrema syndrome: Frequency, criteria, and severity in AQP4-IgG-positive NMOSD.

Shosha E, Dubey D, Palace J, Nakashima I, Jacob A, Fujihara K, Takahashi T, Whittam D, Leite MI, Misu T, Yoshiki T, Messina S, Elsone L, Majed M, Flanagan E, Gadoth A, Huebert C, Sagen J, Greenberg BM, Levy M, Banerjee A, Weinshenker B, Pittock SJ.

Neurology. 2018 Oct 23;91(17):e1642-e1651. doi: 10.1212/WNL.0000000000006392. Epub 2018 Sep 26.

24.

Extranodal NK/T-cell Lymphoma Mimicking Granulomatous Myositis.

Kawaguchi N, Izumi R, Kobayashi M, Tateyama M, Suzuki N, Fujishima F, Fujimori J, Aoki M, Nakashima I.

Intern Med. 2019 Jan 15;58(2):277-282. doi: 10.2169/internalmedicine.0859-18. Epub 2018 Aug 24.

25.

Visual prognosis in seronegative idiopathic optic neuritis finally elucidated: as bad as that in anti-AQP4 antibody-positive optic neuritis.

Akaishi T, Nakashima I.

Eur J Neurol. 2018 Nov;25(11):1305-1306. doi: 10.1111/ene.13772. Epub 2018 Aug 28. No abstract available.

PMID:
30103293
26.

MOG-IgG-associated disease has a stereotypical clinical course, asymptomatic visual impairment and good treatment response.

Pandit L, Mustafa S, Nakashima I, Takahashi T, Kaneko K.

Mult Scler J Exp Transl Clin. 2018 Jul 17;4(3):2055217318787829. doi: 10.1177/2055217318787829. eCollection 2018 Jul-Sep.

27.

CSF cytokine profile in MOG-IgG+ neurological disease is similar to AQP4-IgG+ NMOSD but distinct from MS: a cross-sectional study and potential therapeutic implications.

Kaneko K, Sato DK, Nakashima I, Ogawa R, Akaishi T, Takai Y, Nishiyama S, Takahashi T, Misu T, Kuroda H, Tanaka S, Nomura K, Hashimoto Y, Callegaro D, Steinman L, Fujihara K, Aoki M.

J Neurol Neurosurg Psychiatry. 2018 Sep;89(9):927-936. doi: 10.1136/jnnp-2018-317969. Epub 2018 Jun 6. Erratum in: J Neurol Neurosurg Psychiatry. 2019 Apr;90(4):e4.

28.

Myelin Oligodendrocyte Glycoprotein-IgG-positive Recurrent Bilateral Optic Papillitis with Serous Retinal Detachment.

Kon T, Hikichi H, Ueno T, Suzuki C, Nunomura J, Kaneko K, Takahashi T, Nakashima I, Tomiyama M.

Intern Med. 2018 Nov 15;57(22):3307-3312. doi: 10.2169/internalmedicine.9840-17. Epub 2018 May 18.

29.

Fingolimod-associated PML with mild IRIS in MS: A clinicopathologic study.

Nishiyama S, Misu T, Shishido-Hara Y, Nakamichi K, Saijo M, Takai Y, Takei K, Yamamoto N, Kuroda H, Saito R, Watanabe M, Tominaga T, Nakashima I, Fujihara K, Aoki M.

Neurol Neuroimmunol Neuroinflamm. 2017 Nov 10;5(1):e415. doi: 10.1212/NXI.0000000000000415. eCollection 2018 Jan.

30.

Peripheral blood monocyte count at onset may affect the prognosis in multiple sclerosis.

Akaishi T, Takahashi T, Nakashima I.

J Neuroimmunol. 2018 Jun 15;319:37-40. doi: 10.1016/j.jneuroim.2018.03.016. Epub 2018 Mar 27.

PMID:
29685288
31.

Chaos theory for clinical manifestations in multiple sclerosis.

Akaishi T, Takahashi T, Nakashima I.

Med Hypotheses. 2018 Jun;115:87-93. doi: 10.1016/j.mehy.2018.04.004. Epub 2018 Apr 11.

PMID:
29685206
32.

Human central nervous system astrocytes support survival and activation of B cells: implications for MS pathogenesis.

Touil H, Kobert A, Lebeurrier N, Rieger A, Saikali P, Lambert C, Fawaz L, Moore CS, Prat A, Gommerman J, Antel JP, Itoyama Y, Nakashima I, Bar-Or A; Canadian B Cell Team in MS.

J Neuroinflammation. 2018 Apr 19;15(1):114. doi: 10.1186/s12974-018-1136-2.

33.

Rituximab was effective for acute disseminated encephalomyelitis followed by recurrent optic neuritis with anti-myelin oligodendrocyte glycoprotein antibodies.

Nagashima M, Osaka H, Ikeda T, Matsumoto A, Miyauchi A, Kaneko K, Nakashima I, Nakano Y, Wakabayashi K, Monden Y, Yamagata T.

Brain Dev. 2018 Aug;40(7):607-611. doi: 10.1016/j.braindev.2018.03.011. Epub 2018 Apr 13.

PMID:
29661590
34.

[Autoantibodies in Neuromyelitis Optica Spectrum Disorders].

Nakashima I, Akaishi T.

Brain Nerve. 2018 Apr;70(4):297-304. doi: 10.11477/mf.1416201003. Japanese.

PMID:
29632278
35.

Chloride imbalance is involved in the pathogenesis of optic neuritis in neuromyelitis optica.

Akaishi T, Takahashi T, Himori N, Takeshita T, Nakazawa T, Aoki M, Nakashima I.

J Neuroimmunol. 2018 Jul 15;320:98-100. doi: 10.1016/j.jneuroim.2018.03.010. Epub 2018 Mar 16.

PMID:
29572032
36.

Oligoclonal bands and periventricular lesions in multiple sclerosis will not increase blood-brain barrier permeability.

Akaishi T, Takahashi T, Nakashima I.

J Neurol Sci. 2018 Apr 15;387:129-133. doi: 10.1016/j.jns.2018.02.020. Epub 2018 Feb 6.

PMID:
29571849
37.

Spontaneous Recanalization of the Obstructed Right Coronary Artery Caused by Blunt Chest Trauma.

Haraguchi Y, Sakakura K, Yamamoto K, Taniguchi Y, Nakashima I, Wada H, Sanui M, Momomura SI, Fujita H.

Int Heart J. 2018 Mar 30;59(2):407-412. doi: 10.1536/ihj.17-173. Epub 2018 Feb 23.

38.

CV2/CRMP5-antibody-related Paraneoplastic Optic Neuropathy Associated with Small-cell Lung Cancer.

Nakajima M, Uchibori A, Ogawa Y, Miyazaki T, Ichikawa Y, Kaneko K, Takahashi T, Nakashima I, Shiraishi H, Motomura M, Chiba A.

Intern Med. 2018 Jun 1;57(11):1645-1649. doi: 10.2169/internalmedicine.9736-17. Epub 2018 Jan 11.

39.

Chloride imbalance between serum and CSF in the acute phase of neuromyelitis optica.

Akaishi T, Takahashi T, Nakashima I.

J Neuroimmunol. 2018 Feb 15;315:45-49. doi: 10.1016/j.jneuroim.2017.12.019. Epub 2017 Dec 21.

PMID:
29306405
40.

Cognitive impairment in neuromyelitis optica spectrum disorders: A comparison of the Wechsler Adult Intelligence Scale-III and the Wechsler Memory Scale Revised with the Rao Brief Repeatable Neuropsychological Battery.

Fujimori J, Nakashima I, Baba T, Meguro Y, Ogawa R, Fujihara K.

eNeurologicalSci. 2017 Sep 21;9:3-7. doi: 10.1016/j.ensci.2017.09.001. eCollection 2017 Dec.

41.
42.

[Anti-MOG Antibody Associated Diseases].

Nakashima I.

Brain Nerve. 2017 Nov;69(11):1331-1336. doi: 10.11477/mf.1416200912. Review. Japanese.

PMID:
29172198
43.

Subclinical retinal atrophy in the unaffected fellow eyes of multiple sclerosis and neuromyelitis optica.

Akaishi T, Kaneko K, Himori N, Takeshita T, Takahashi T, Nakazawa T, Aoki M, Nakashima I.

J Neuroimmunol. 2017 Dec 15;313:10-15. doi: 10.1016/j.jneuroim.2017.10.001. Epub 2017 Oct 3.

PMID:
29153600
44.

Reversible paraspinal muscle hyperintensity in anti-MOG antibody-associated transverse myelitis.

Pandit L, Mustafa S, Uppoor R, Nakashima I, Takahashi T, Kaneko K.

Neurol Neuroimmunol Neuroinflamm. 2017 Oct 27;5(1):e412. doi: 10.1212/NXI.0000000000000412. eCollection 2018 Jan. No abstract available.

45.

[A case of recurrent myelitis associated with anti-myelin oligodendrocyte glycoprotein antibody that developed only as localized short spinal cord lesions].

Matsumoto A, Kaneko K, Takahashi T, Nakashima I, Hisanaga K, Nagano I.

Rinsho Shinkeigaku. 2017 Nov 25;57(11):729-732. doi: 10.5692/clinicalneurol.cn-001014. Epub 2017 Oct 26. Japanese.

PMID:
29070750
46.

A case of MOG antibody-positive bilateral optic neuritis and meningoganglionitis following a genital herpes simplex virus infection.

Nakamura M, Iwasaki Y, Takahashi T, Kaneko K, Nakashima I, Kunieda T, Kaneko S, Kusaka H.

Mult Scler Relat Disord. 2017 Oct;17:148-150. doi: 10.1016/j.msard.2017.07.023. Epub 2017 Jul 27.

PMID:
29055448
47.

Prevalence and clinical features of neuromyelitis optica spectrum disorders in northern Japan.

Houzen H, Kondo K, Niino M, Horiuchi K, Takahashi T, Nakashima I, Tanaka K.

Neurology. 2017 Nov 7;89(19):1995-2001. doi: 10.1212/WNL.0000000000004611. Epub 2017 Oct 6.

PMID:
28986408
48.

Efficiency of antibody therapy in demyelinating diseases.

Akaishi T, Nakashima I.

Int Immunol. 2017 Jul 1;29(7):327-335. doi: 10.1093/intimm/dxx037. Review.

PMID:
28910968
49.

Is MOG-IgG another biomarker for neuromyelitis optica?

Nakashima I.

J Neurol Neurosurg Psychiatry. 2017 Oct;88(10):807. doi: 10.1136/jnnp-2017-316247. Epub 2017 Jul 6. No abstract available.

PMID:
28684533
50.

Clinical features in very early-onset demyelinating disease with anti-MOG antibody.

Nishiyama M, Nagase H, Matsumoto M, Tomioka K, Awano H, Tanaka T, Toyoshima D, Fujita K, Maruyama A, Oyazato Y, Saeki K, Shiraishi K, Takada S, Kaneko K, Takahashi T, Nakashima I, Iijima K.

Brain Dev. 2017 Oct;39(9):756-762. doi: 10.1016/j.braindev.2017.05.004. Epub 2017 May 24.

PMID:
28551039

Supplemental Content

Loading ...
Support Center